Word: nci
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...National Cancer Institute (NCI) has awarded Harvard and MIT a five-year, $20 million grant to establish a center geared toward applying nanotechnology to cancer research. The MIT-Harvard Center of Cancer Nanotechnology Excellence (CCNE) will be one of seven centers across the nation, the NCI announced on Oct. 3. Ralph Weissleder, a professor of radiology at Harvard Medical School (HMS) and director of the Center for Molecular Imaging Research at Massachusetts General Hospital, and Robert Langer, an Institute Professor in MIT’s Department of Chemical Engineering, will head the new center. “We?...
...Commissioner Lester Crawford just two months after his confirmation. (The Senate is investigating a possible failure to disclose financial interests.) Von Eschenbach, a Texas urologist with close ties to the Bush family, has no regulatory experience. Plus, he's already fully engaged. He has headed the National Cancer Institute (NCI) since 2002. The plan: have him do both jobs...
...time cancer survivor is known for taking on outsize tasks, reflected best in his controversial vow to "end suffering and death due to cancer" by 2015. In a letter to the heads of major U.S. cancer centers, he talked up the virtue of having the FDA and NCI "work together" to smooth the path from lab bench to bedside...
...where the new chief sees synergy, others see conflict of interest. NCI supports research on treatments reviewed by the FDA. "How can you wear both hats and be true to the missions of both organizations?" asks Merrill Goozner of the Center for Science in the Public Interest. Von Eschenbach also sits on the board of a nonprofit cancer advocacy group called C-Change--along with execs from major drug firms...
Such concerns led to the Administration's own Plan B. While remaining at NCI, von Eschenbach will turn over day-to-day management to deputy Dr. John Niederhuber. The acting FDA chief also reassured his staff that he "will not participate in certain FDA matters in which NCI is a party"--unless requested. --By Claudia Wallis and Eric Roston